Suchergebnisse - "Zhao, Hui"

PubPharm (80)

1

DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors

enthalten in: Molecular carcinogenesis | 2024

von Liu, A. | Zhang, S. | Wang, M. | +14

2

SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2023

von Li, S. | Zhao, S. | Liang, N. | +13

3

Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation : A pooled analysis of two clinical studies

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Yang, S. | Wu, S. | Zhao, Y. | +54

4

Tumor microenvironment responded naturally extracted FOF1-ATPase loaded chromatophores for antitumor therapy

enthalten in: International journal of biological macromolecules | 2023

von Hong, W. | Lou, B. | Gao, Y. | +6

5

Marine Sponge-Derived Alkaloid Induces Mitochondrial Dysfunction and Inhibits the PI3K/AKT/mTOR Signaling Pathway against Burkitt's Lymphoma

enthalten in: Journal of natural products | 2023

von Zhao, H. | He, J. | Chang, Y. | +4

6

Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC : A Phase 2b Study

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2022

von Shi, Y. | Wu, S. | Wang, K. | +46

7

Synthesis and biological evaluation of BU-4664L derivatives as potential anticancer agents

enthalten in: Bioorganic & medicinal chemistry letters | 2022

von Liu, C. | Xu, Y. | Wen, Z. | +2

8

Duocarmycin-based antibody-drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy : Pharmaceutical strategy and clinical progress

enthalten in: Drug discovery today | 2021

von Yao, H. | Zhao, H. | Hudson, R. | +2

9

Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance Market

enthalten in: JNCI cancer spectrum | 2021

von Shih, Y. | Xu, Y. | Zhao, H. | +2

10

Delayed initiation of adjuvant chemotherapy in older women with breast cancer

enthalten in: Cancer medicine | 2020

von Smith-Graziani, D. | Lei, X. | Giordano, S. | +3

1
2
3
4
5
6
7
8
Nächster »
[8]